Orange Book product
TREXIMET 500MG;EQ 85MG BASE
Orange Book NDA 021926 · AZURITY PHARMACEUTICALS INC · Prescription
Key facts
| Proprietary name | TREXIMET |
|---|---|
| Active ingredients | NAPROXEN SODIUM, SUMATRIPTAN SUCCINATE |
| Strength | 500MG;EQ 85MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Application | NDA021926 |
| Applicant holder | AZURITY PHARMACEUTICALS INC |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AB |
| Reference listed drug (RLD) | Yes |
| Reference standard (RS) | Yes |
| Approval date | Apr 15, 2008 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- Yes Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.